| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.089 | 0.2 |